Jessica Hergert

Assistant Editor, OncLive®
Jessica joined the company in August 2019 and is one of the point contacts for the OncLive On Air™ podcast. She is a Rider University alumna and holds a degree in journalism and biology. Prior to joining MJH Life Sciences, she interned with the Ireland-based social media monitoring agency Olytico and served as a copy editor and writer for The Rider News. Email: jhergert@onclive.com

Articles

Choueiri Pushes for Discussion and Collaboration in Kidney Cancer

September 17th 2019

Toni Choueiri, MD, discusses the rationale behind the Kidney Cancer Research Summit and recent advances in the renal cell carcinoma landscape.

Novel Therapies Propelling Progress in Breast Cancer

September 12th 2019

Alexander A. Hindenburg, MD, discusses novel agents and ongoing clinical trials supporting their future application in metastatic, hormone receptor–positive, HER2-negative breast cancer.

Novel Approaches Push the Envelope in HER2+ Breast Cancer

September 9th 2019

Douglas K. Marks, MD, discusses key developments in the HER2-positive breast cancer space and shed light on novel approaches under investigation.

Shorter Adjuvant Oxaliplatin-Based Therapy Less Effective in High-Risk Stage II CRC

September 6th 2019

Three months of adjuvant oxaliplatin-based therapy in patients with high-risk, stage II colorectal cancer was found to be inferior to 6 months of treatment.

Blood Cancer Treatment Continues to Shift Away From Chemotherapy

September 6th 2019

Steven T. Rosen, MD, discusses the rapid evolution in hematologic cancer treatment and highlighted challenges that have recently emerged.

Larotrectinib Success Underscores Need for NGS to Detect TRK Fusion-Positive Cancers

September 4th 2019

Alexander Drilon, MD, provides insight into his study on the role of larotrectinib in the treatment of patients with TRK fusions and brain metastases or those with primary CNS disease.

Novel Frontline Approaches Induce Deep, Durable Responses in Multiple Myeloma

September 3rd 2019

Michael A. Rosenzweig, MD, MS, discusses changes in the frontline setting of multiple myeloma.

Navigating Among Maintenance Options in Advanced Ovarian Cancer

August 30th 2019

Camille C. Gunderson, MD, discusses the various maintenance options available in advanced ovarian cancer, as well as what factors should be considered for selecting each approach.

Novel Antibody-Based Approaches on Horizon in Multiple Myeloma

August 30th 2019

Hearn Jay Cho, MD, PhD, provides background on these novel approaches, while highlighting exciting trials to look for in the future.

Hope Is Not Lost on Hunt for Effective Ovarian Cancer Screening Test

August 28th 2019

Laura L. Holman, MD, discusses ongoing efforts in ovarian cancer screening and what may lie ahead for generations to come.

Tracers Increase PET Imaging Sensitivity in Prostate Cancer

August 27th 2019

Manoj K. Jain, MD, discusses new imaging modalities and what they could mean for the field going forward.

Research Initiative Comparing Proton Therapy With IMRT in Prostate Cancer

August 27th 2019

Randal Henderson, MD, MBA, discusses the data that led to the PCORI-funded trial, what the results could mean for the field, and interesting research on the horizon.